Mary Ann Lila
agricultural & plant health advisor
Ph.D., Plant Biology, University of Wisconsin
M.S., Plant Pathology, University of Illinois
B.S., Horticultural Sciences, University of Illinois
Director, Plants for Human Health Institute, NC State University
Cofounder, Global Institute for BioExploration, Rutgers University
Professor, University of Illinois
Through ground-breaking, transdisciplinary discovery and outreach, Mary Ann Lila and her team of faculty at the PHHI pioneer a dramatic shift in the way the American public views and uses food crops – not merely as a source of nutrients and flavorful calories, but as a powerful resource for components that protect and enhance human health.
Integrated research in metabolomics, biochemistry, pharmacogenomics, molecular breeding, regenerative medicine, translational food science and nutrition and postharvest are aimed at development and promotion of mainstream fruit and vegetable produce with enhanced health benefits, and introduction of new or underappreciated crops and products from various sites throughout the globe, allowing consumers to make proactive, responsible dietary choices that benefit their own, and their families’ health.
Dr. Lila is currently a co-Director of an ambitious public-private Plant Pathways Elucidation Project (P2EP) which synergizes the talents of academia and industry, and is co-PI of an ambitious Seedings Solutions project funded by the Foundation for Food and Agricultural Research, which centers on elucidating the individualized nutritional outcomes to interventions, based on individual microbiome profiles and metagenomics.
market development & supply chain advisor
M.S., Management, NC State University
B.S., Mechanical Engineering, NC State University
Chief Executive Officer, Dexios
Vice President of Operations, Keratin Biosciences, Inc.
Chief Operating Officer, Ei – A Pharmaceutical SolutionWorks
Plant Manager, Nestle
Department Manager, Proctor & Gamble
With more than 20 years of experience delivering results in a variety of environments that includes start-up, rampant growth, and turnaround, Dave Parker has built a career on true value creation. He has a strong bias toward action, and passion to win.
Mr. Parker formed a solid foundation of performance through principle-based leadership while in engineering and management positions at IBM and Procter & Gamble and further expanded his reach by creating and implementing corporate continuous improvement strategies. As founder and Principal of Dedicated Partners, Mr. Parker began to leverage his knowledge and experience by partnering with executive teams and board members to achieve their objectives more quickly and effectively.
In 2016, Mr. Parker and his team formed Dexios, a specialty manufacturing business with core competencies in the development and manufacturing of therapeutic skin care products and cGMP manufacturing across a breadth of platforms. Mr. Parker’s unique combination of capability, humility and authenticity enable him to quickly build relationships within organizations, and with customers and clients, He values trust and understands the impact of the individual as well as the criticality of the team. Mr. Parker grew up in an Air Force family and has lived all over the world, including Europe. He currently lives in Charlotte, NC with his family.
skin science & military industry advisor
Ph.D., Neurobiology & Anatomy, Wake Forest University
M.A., Strategic Studies, US Army War College
B.A., Psychology, Sonoma State University
Chief Scientific Officer, Keratin Biosciences Inc.
Adjunct Assistant Professor, Department of Orthopaedic Surgery, Wake Forest University
Luke Burnett is the Chief Science Officer at Keratin Biosciences and an Adjunct Associate Professor in the Department of Orthopaedic Surgery at Wake Forest School of Medicine.
Dr. Burnett has worked in the field of biomaterials for over a decade with a focus on product development of keratin biomaterial applications to wound healing and tissue engineering.
Dr. Burnett has an extensive funding history where he has been the PI or Co-I on more than 27 federally-funded grants from agencies such as CDMRP, DoD, NIH and BARDA in the last 8 years. Dr. Burnett has published research using trauma models in multiple species published in major scientific journals, and filed 7 patents on the work conducted in his lab.
Dr. Burnett recently retired as a Colonel from the US Army where he served 27 years, including two tours in Iraq.